A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression – the way to go? Results from a pilot randomised controlled trial

Abstract

Get full access to this article

View all access options for this article.

References

Aan het Rot

Collins

Murrough

et al . (2010) Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 67: 139–145.

Djupesland

(2013) Nasal drug delivery devices: Characteristics and performance in a clinical perspective—a review. Drug Deliv Transl Res 3: 42–62.

Foo

Cheng

et al . (2007) The influence of spray properties on intranasal deposition. J Aerosol Med 20: 495–508.

Gálvez

Huggins

et al . (2018) Repeated Intranasal ketamine for treatment resistant depression – the way to go? Results from a pilot randomised controlled trial. J Psychopharmacol 37: 397–407.

Guastella

Hickie

McGuinness

et al . (2013) Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology 38: 612–625.

Guo

Laube

Dalby

(2005) The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model. Pharm Res 22: 1871–1878.

Lapidus

Levitch

Perez

et al . (2014) A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry 76: 970–976.

Lee

Archer

McGuinness

et al . (2019) A response to: Repeated Intranasal Ketamine for Treatment Resistant Depression – The Way to Go? Results from a Pilot Randomised Controlled Trial. J Psychopharmacol 33: 258–259.

Murrough

Perez

Pillemer

et al . (2013) Rapid and longerterm antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 74: 250–256.

10.

Naranjo

Busto

Sellers

(1982) Difficulties in assessing adverse drug reactions in clinical trials. Prog Neuropsychopharmacol Biol Psychiatry 6: 651–657.

11.

Rasmussen

Lineberry

Galardy

et al . (2013) Serial infusions of low-dose ketamine for major depression. J Psychopharmacol 27: 444–450.

12.

Segmiller

Ruther

Linhardt

et al . (2013) Repeated S-ketamine infusions in therapy resistant depression: A case series. J Clin Pharmacol 53: 996–998.

13.

Shiroma

Johns

Kuskowski

et al . (2014) Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression. J Affect Disord 155: 123–129.

14.

Short

Fong

Galvez

et al (2018) Side-effects associated with ketamine use in depression: A systematic review. Lancet Psychiatry 5: 65–78.